DalsnaFinance

Can Fite Biopharma stock surges 65% on pancreatic cancer data

Markets Investing.com By Investing.com 01 Jul 2026 14:08 1 min read
Can Fite Biopharma stock surges 65% on pancreatic cancer data

Can Fite Biopharma stock surges 65% on pancreatic cancer data

Can Fite Biopharma stock surges 65% on pancreatic cancer data

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.